Features
2021 Canadian ECP Myopia Study results now available
Thursday, October 7 2021 | 15 h 56 min | Contest, News, Survey,
A new 2021 report on how Canadian ECPs are engaged in myopia treatment is now available. The current 2021 report updates these perceptions against the background of extensive practitioner education over the past 18 months and more specific treatment options available.
FYidoctors Doubles Retail Offering in Hometown Grande Prairie
Thursday, October 7 2021 | 14 h 10 min | News, Press Release,
The newly constructed clinic, which is located on Westgate Drive, marks a significant milestone for the organization, whose entrepreneurial success story began 13 years ago in the growing community.
CRAVING MIDO: Ready to Restart and to Transform the Wonder into a New Beginning
Thursday, October 7 2021 | 09 h 13 min | Events, News, Press Release,
Starting today, on the MIDO website www.mido.com, visitors to the international eyewear show can register for the forthcoming edition of the show, set to take place February 12-14, 2022.
Bausch + Lomb Announces Statistically Significant Topline Results from Second Phase 3 Trial of NOV03
Wednesday, October 6 2021 | 11 h 29 min | News, Press Release,
All Primary and Secondary Endpoints Were Achieved; Bausch + Lomb Plans to Submit NDA to FDA in 2022.
CooperVision: SightGlass Vision Diffusion Optics Technology Demonstrates Significant Reduction in Myopia Progression
Wednesday, October 6 2021 | 11 h 27 min | News, Press Release,
Data Shared in Conjunction with the World’s First Commercial Availability of the Innovative Spectacle Lenses in the Netherlands
2021 Canadian ECP Myopia Study results now available
Thursday, October 7 2021 | 15 h 56 min | Contest, News, Survey,
A new 2021 report on how Canadian ECPs are engaged in myopia treatment is now available. The current 2021 report updates these perceptions against the background of extensive practitioner education over the past 18 months and more specific treatment options available.
FYidoctors Doubles Retail Offering in Hometown Grande Prairie
Thursday, October 7 2021 | 14 h 10 min | News, Press Release,
The newly constructed clinic, which is located on Westgate Drive, marks a significant milestone for the organization, whose entrepreneurial success story began 13 years ago in the growing community.
CRAVING MIDO: Ready to Restart and to Transform the Wonder into a New Beginning
Thursday, October 7 2021 | 09 h 13 min | Events, News, Press Release,
Starting today, on the MIDO website www.mido.com, visitors to the international eyewear show can register for the forthcoming edition of the show, set to take place February 12-14, 2022.
Bausch + Lomb Announces Statistically Significant Topline Results from Second Phase 3 Trial of NOV03
Wednesday, October 6 2021 | 11 h 29 min | News, Press Release,
All Primary and Secondary Endpoints Were Achieved; Bausch + Lomb Plans to Submit NDA to FDA in 2022.
CooperVision: SightGlass Vision Diffusion Optics Technology Demonstrates Significant Reduction in Myopia Progression
Wednesday, October 6 2021 | 11 h 27 min | News, Press Release,
Data Shared in Conjunction with the World’s First Commercial Availability of the Innovative Spectacle Lenses in the Netherlands
2021 Canadian ECP Myopia Study results now available
Thursday, October 7 2021 | 15 h 56 min | Contest, News, Survey,
A new 2021 report on how Canadian ECPs are engaged in myopia treatment is now available. The current 2021 report updates these perceptions against the background of extensive practitioner education over the past 18 months and more specific treatment options available.
FYidoctors Doubles Retail Offering in Hometown Grande Prairie
Thursday, October 7 2021 | 14 h 10 min | News, Press Release,
The newly constructed clinic, which is located on Westgate Drive, marks a significant milestone for the organization, whose entrepreneurial success story began 13 years ago in the growing community.
CRAVING MIDO: Ready to Restart and to Transform the Wonder into a New Beginning
Thursday, October 7 2021 | 09 h 13 min | Events, News, Press Release,
Starting today, on the MIDO website www.mido.com, visitors to the international eyewear show can register for the forthcoming edition of the show, set to take place February 12-14, 2022.
Bausch + Lomb Announces Statistically Significant Topline Results from Second Phase 3 Trial of NOV03
Wednesday, October 6 2021 | 11 h 29 min | News, Press Release,
All Primary and Secondary Endpoints Were Achieved; Bausch + Lomb Plans to Submit NDA to FDA in 2022.
CooperVision: SightGlass Vision Diffusion Optics Technology Demonstrates Significant Reduction in Myopia Progression
Wednesday, October 6 2021 | 11 h 27 min | News, Press Release,
Data Shared in Conjunction with the World’s First Commercial Availability of the Innovative Spectacle Lenses in the Netherlands
2021 Canadian ECP Myopia Study results now available
Thursday, October 7 2021 | 15 h 56 min | Contest, News, Survey,
A new 2021 report on how Canadian ECPs are engaged in myopia treatment is now available. The current 2021 report updates these perceptions against the background of extensive practitioner education over the past 18 months and more specific treatment options available.
FYidoctors Doubles Retail Offering in Hometown Grande Prairie
Thursday, October 7 2021 | 14 h 10 min | News, Press Release,
The newly constructed clinic, which is located on Westgate Drive, marks a significant milestone for the organization, whose entrepreneurial success story began 13 years ago in the growing community.
CRAVING MIDO: Ready to Restart and to Transform the Wonder into a New Beginning
Thursday, October 7 2021 | 09 h 13 min | Events, News, Press Release,
Starting today, on the MIDO website www.mido.com, visitors to the international eyewear show can register for the forthcoming edition of the show, set to take place February 12-14, 2022.
Bausch + Lomb Announces Statistically Significant Topline Results from Second Phase 3 Trial of NOV03
Wednesday, October 6 2021 | 11 h 29 min | News, Press Release,
All Primary and Secondary Endpoints Were Achieved; Bausch + Lomb Plans to Submit NDA to FDA in 2022.
CooperVision: SightGlass Vision Diffusion Optics Technology Demonstrates Significant Reduction in Myopia Progression
Wednesday, October 6 2021 | 11 h 27 min | News, Press Release,
Data Shared in Conjunction with the World’s First Commercial Availability of the Innovative Spectacle Lenses in the Netherlands
